A new study shows that Medasense's NOL monitoring during major abdominal surgery can significantly reduce the proportion of patients with severe post-operative pain. The study found that intraoperative opioid dosing based on the NOL index reduced PACU pain scores by a median of 1.5 points at 90 minutes post-surgery. This technology use...
A new randomized, controlled trial demonstrates that Medasense's NOL monitoring during major abdominal surgery can reduce postoperative pain by 30% compared to standard care. The study found that personalized fentanyl dosing with NOL guidance leads to lower sympathetic activation and surgical stress, resulting in reduced PACU pain scores.
A new study published in European Journal of Anaesthesiology found that NOL pain monitoring technology can detect the effect of dexmedetomidine on patients' pain response, enabling administration of less intraoperative opioids. The study demonstrated the potential for significant opioid sparing during surgery.